Adverse drug reactions associated with drugs inducing osteoporosis

Mohammed Taqui; Swamivelmanickam M; Mohathasim Billah A

doi:10.5455/njppp.2021.11.12367202020122020

Review Article
Online Published: 30 Dec 2020

Natl J Physiol Pharm Pharmacol. 2021; 11(4): 356-359

doi: 10.5455/njppp.2021.11.12367202020122020

Adverse drug reactions associated with drugs inducing osteoporosis

Mohammed Taqui, Swamivelmanickam M, Mohathasim Billah A.

Cited By:17

Abstract
Drug-induced osteoporosis has a widespread and has a profound impact on the prognosis of patients in chronically serious patients. The most common medicines that cause osteoporotic fractures have been glucocorticoids but in women therapy with aromatase inhibitors, fractural osteoporosis is also identified, Type 2 diabetes mellitus treatment for men and women who are treated with antiandrogen therapy in prostate cancer and women treated with elevated amounts of thyroxine following menopausal procedures. Fracture bone loss also occurs with people who are treated with immune systems drugs such as calcineurin inhibitors, proton-pump inhibitors, heparin, antiretrovirals, loop diuretics, serotonin reuptake selective inhibitors, oral anticoagulants, and anticonvulsants.

Key words: Drugs; Fractures; Osteoporosis; Secondary Osteoporosis

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Mohammed Taqui Articles by Swamivelmanickam M Articles by Mohathasim Billah A
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Taqui M, M S, A MB. Adverse drug reactions associated with drugs inducing osteoporosis. Natl J Physiol Pharm Pharmacol. 2021; 11(4): 356-359.

doi:10.5455/njppp.2021.11.12367202020122020

Web Style

Taqui M, M S, A MB. Adverse drug reactions associated with drugs inducing osteoporosis. https://www.njppp.com/?mno=32269 [Access: June 27, 2026].

doi:10.5455/njppp.2021.11.12367202020122020

AMA (American Medical Association) Style

Taqui M, M S, A MB. Adverse drug reactions associated with drugs inducing osteoporosis. Natl J Physiol Pharm Pharmacol. 2021; 11(4): 356-359.

doi:10.5455/njppp.2021.11.12367202020122020

Vancouver/ICMJE Style

Taqui M, M S, A MB. Adverse drug reactions associated with drugs inducing osteoporosis. Natl J Physiol Pharm Pharmacol. (2021), [cited June 27, 2026]; 11(4): 356-359.

doi:10.5455/njppp.2021.11.12367202020122020

Harvard Style

Taqui, M., M, . S. & A, . M. B. (2021) Adverse drug reactions associated with drugs inducing osteoporosis. Natl J Physiol Pharm Pharmacol, 11 (4), 356-359.

doi:10.5455/njppp.2021.11.12367202020122020

Turabian Style

Taqui, Mohammed, Swamivelmanickam M, and Mohathasim Billah A. 2021. Adverse drug reactions associated with drugs inducing osteoporosis. National Journal of Physiology, Pharmacy and Pharmacology, 11 (4), 356-359.

doi:10.5455/njppp.2021.11.12367202020122020

Chicago Style

Taqui, Mohammed, Swamivelmanickam M, and Mohathasim Billah A. "Adverse drug reactions associated with drugs inducing osteoporosis." National Journal of Physiology, Pharmacy and Pharmacology 11 (2021), 356-359.

doi:10.5455/njppp.2021.11.12367202020122020

MLA (The Modern Language Association) Style

doi:10.5455/njppp.2021.11.12367202020122020

APA (American Psychological Association) Style

Taqui, M., M, . S. & A, . M. B. (2021) Adverse drug reactions associated with drugs inducing osteoporosis. National Journal of Physiology, Pharmacy and Pharmacology, 11 (4), 356-359.

doi:10.5455/njppp.2021.11.12367202020122020

About National Journal of Physiology, Pharmacy and Pharmacology

Contact Information

How to cite this article